20-46014194-A-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004994.3(MMP9):​c.1821A>C​(p.Gly607Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.572 in 1,537,284 control chromosomes in the GnomAD database, including 257,695 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 21915 hom., cov: 33)
Exomes 𝑓: 0.58 ( 235780 hom. )

Consequence

MMP9
NM_004994.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.24

Publications

32 publications found
Variant links:
Genes affected
MMP9 (HGNC:7176): (matrix metallopeptidase 9) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008]
SLC12A5-AS1 (HGNC:53143): (SLC12A5 and MMP9 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 20-46014194-A-C is Benign according to our data. Variant chr20-46014194-A-C is described in ClinVar as Benign. ClinVar VariationId is 285363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.603 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP9NM_004994.3 linkc.1821A>C p.Gly607Gly synonymous_variant Exon 11 of 13 ENST00000372330.3 NP_004985.2 P14780
SLC12A5-AS1NR_147699.1 linkn.1263T>G non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP9ENST00000372330.3 linkc.1821A>C p.Gly607Gly synonymous_variant Exon 11 of 13 1 NM_004994.3 ENSP00000361405.3 P14780
SLC12A5-AS1ENST00000535913.2 linkn.1263T>G non_coding_transcript_exon_variant Exon 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80229
AN:
151966
Hom.:
21914
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.433
Gnomad AMI
AF:
0.651
Gnomad AMR
AF:
0.542
Gnomad ASJ
AF:
0.573
Gnomad EAS
AF:
0.239
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.540
Gnomad MID
AF:
0.598
Gnomad NFE
AF:
0.607
Gnomad OTH
AF:
0.555
GnomAD2 exomes
AF:
0.499
AC:
67779
AN:
135832
AF XY:
0.497
show subpopulations
Gnomad AFR exome
AF:
0.415
Gnomad AMR exome
AF:
0.457
Gnomad ASJ exome
AF:
0.565
Gnomad EAS exome
AF:
0.246
Gnomad FIN exome
AF:
0.533
Gnomad NFE exome
AF:
0.606
Gnomad OTH exome
AF:
0.543
GnomAD4 exome
AF:
0.577
AC:
799523
AN:
1385202
Hom.:
235780
Cov.:
63
AF XY:
0.573
AC XY:
391217
AN XY:
683186
show subpopulations
African (AFR)
AF:
0.423
AC:
13302
AN:
31436
American (AMR)
AF:
0.466
AC:
16507
AN:
35394
Ashkenazi Jewish (ASJ)
AF:
0.566
AC:
14180
AN:
25056
East Asian (EAS)
AF:
0.239
AC:
8538
AN:
35672
South Asian (SAS)
AF:
0.403
AC:
31842
AN:
79006
European-Finnish (FIN)
AF:
0.547
AC:
21614
AN:
39494
Middle Eastern (MID)
AF:
0.589
AC:
2871
AN:
4878
European-Non Finnish (NFE)
AF:
0.611
AC:
658348
AN:
1076632
Other (OTH)
AF:
0.561
AC:
32321
AN:
57634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
20000
39999
59999
79998
99998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17864
35728
53592
71456
89320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.528
AC:
80263
AN:
152082
Hom.:
21915
Cov.:
33
AF XY:
0.521
AC XY:
38745
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.433
AC:
17978
AN:
41498
American (AMR)
AF:
0.542
AC:
8282
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
1989
AN:
3470
East Asian (EAS)
AF:
0.238
AC:
1227
AN:
5148
South Asian (SAS)
AF:
0.387
AC:
1863
AN:
4818
European-Finnish (FIN)
AF:
0.540
AC:
5720
AN:
10590
Middle Eastern (MID)
AF:
0.605
AC:
178
AN:
294
European-Non Finnish (NFE)
AF:
0.607
AC:
41276
AN:
67952
Other (OTH)
AF:
0.549
AC:
1160
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1938
3876
5813
7751
9689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.530
Hom.:
4186
Bravo
AF:
0.520
Asia WGS
AF:
0.317
AC:
1107
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Metaphyseal anadysplasia 2 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 28, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.74
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13969; hg19: chr20-44642833; COSMIC: COSV63433888; API